GB0314097D0 - Combination therapy - Google Patents

Combination therapy

Info

Publication number
GB0314097D0
GB0314097D0 GB0314097A GB0314097A GB0314097D0 GB 0314097 D0 GB0314097 D0 GB 0314097D0 GB 0314097 A GB0314097 A GB 0314097A GB 0314097 A GB0314097 A GB 0314097A GB 0314097 D0 GB0314097 D0 GB 0314097D0
Authority
GB
United Kingdom
Prior art keywords
combination therapy
therapy
combination
Prior art date
Legal status (The legal status is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the status listed.)
Ceased
Application number
GB0314097A
Current Assignee (The listed assignees may be inaccurate. Google has not performed a legal analysis and makes no representation or warranty as to the accuracy of the list.)
AstraZeneca AB
Original Assignee
AstraZeneca AB
Priority date (The priority date is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the date listed.)
Filing date
Publication date
Application filed by AstraZeneca AB filed Critical AstraZeneca AB
Priority to GB0314097A priority Critical patent/GB0314097D0/en
Publication of GB0314097D0 publication Critical patent/GB0314097D0/en
Priority to US10/561,183 priority patent/US20060142239A1/en
Priority to BRPI0411567-8A priority patent/BRPI0411567A/en
Priority to CN 200480023133 priority patent/CN1835757A/en
Priority to CA002529409A priority patent/CA2529409A1/en
Priority to KR1020057024244A priority patent/KR20060036058A/en
Priority to PCT/GB2004/002624 priority patent/WO2004112801A2/en
Priority to AU2004248968A priority patent/AU2004248968A1/en
Priority to EP04742979A priority patent/EP1658084A2/en
Priority to JP2006516444A priority patent/JP2006527753A/en
Priority to MXPA05013827A priority patent/MXPA05013827A/en
Priority to NO20055888A priority patent/NO20055888L/en
Priority to IL172560A priority patent/IL172560A0/en
Priority to ZA200510258A priority patent/ZA200510258B/en
Ceased legal-status Critical Current

Links

GB0314097A 2003-06-18 2003-06-18 Combination therapy Ceased GB0314097D0 (en)

Priority Applications (14)

Application Number Priority Date Filing Date Title
GB0314097A GB0314097D0 (en) 2003-06-18 2003-06-18 Combination therapy
MXPA05013827A MXPA05013827A (en) 2003-06-18 2004-06-18 Compositions comprising zd6126 together with 5-fu, cpt-11 or 5-fu and cpt-11 having vascular damaging activity for treating e.g. colorectal cancer.
PCT/GB2004/002624 WO2004112801A2 (en) 2003-06-18 2004-06-18 Compositions comprising zd6126 together with 5-fu, cpt-11 or 5-fu and cpt-11 having vascular damaging activity for treating e.g. colorectal cancer
EP04742979A EP1658084A2 (en) 2003-06-18 2004-06-18 Compositions comprising zd6126 together with 5-fu, cpt-11 or 5-fu and cpt-11 having vascular damaging activity for treating e.g. colorectal cancer
CN 200480023133 CN1835757A (en) 2003-06-18 2004-06-18 Compositions comprising ZD6126 together with 5-FU, CPT-11 or 5-FU and CPT-11 having vascular damaging activity for treating e.g. colorectal cancer
CA002529409A CA2529409A1 (en) 2003-06-18 2004-06-18 Compositions comprising zd6126 together with 5-fu, cpt-11 or 5-fu and cpt-11 having vascular damaging activity for treating e.g. colorectal cancer
KR1020057024244A KR20060036058A (en) 2003-06-18 2004-06-18 Compositions comprising zd6126 together with 5-fu, cpt-11 or 5-fu and cpt-11 having vascular damaging activity for treating e.g. colorectal cancer
US10/561,183 US20060142239A1 (en) 2003-06-18 2004-06-18 Potassium or sodium salt of (-)-2-(4-hydroxyphenyl)ethyl!-thio-3-'4-{4-'(methzlsulfonzl)oxy !phenoxy}phenyl!propanoic acid and their use in medicine
AU2004248968A AU2004248968A1 (en) 2003-06-18 2004-06-18 Compositions comprising ZD6126 together with 5-FU, CPT-11 or 5-FU and CPT-11 having vascular damaging activity for treating e.g. colorectal cancer
BRPI0411567-8A BRPI0411567A (en) 2003-06-18 2004-06-18 use of zd6126 or a pharmaceutically acceptable salt thereof and one of 5-fu, cpt-11, and 5-fu and cpt-11, pharmaceutical composition, kit, and methods for producing a vascular damage effect in an animal of warm blood and for the treatment of a cancer involving a solid tumor in a warm blooded animal
JP2006516444A JP2006527753A (en) 2003-06-18 2004-06-18 Composition comprising ZD6126 in combination with 5-FU, CPT-11 or 5-FU and CPT-11 having vascular damage effects for the treatment of colorectal cancer and the like
NO20055888A NO20055888L (en) 2003-06-18 2005-12-12 combination therapy
IL172560A IL172560A0 (en) 2003-06-18 2005-12-13 Compositions comprisingzd 6126 together with 5-fu, cpt-11 or 5-fu and cpt-11 having vascular damaging activity for treating e.g. colorectal cancer
ZA200510258A ZA200510258B (en) 2003-06-18 2005-12-15 Compositions comprising ZD6126 together with 5-FU, CPT-11 or 5-FU and CPT-11 having vascular damaging activity for treating e.g. colorectal cancer

Applications Claiming Priority (1)

Application Number Priority Date Filing Date Title
GB0314097A GB0314097D0 (en) 2003-06-18 2003-06-18 Combination therapy

Publications (1)

Publication Number Publication Date
GB0314097D0 true GB0314097D0 (en) 2003-07-23

Family

ID=27636766

Family Applications (1)

Application Number Title Priority Date Filing Date
GB0314097A Ceased GB0314097D0 (en) 2003-06-18 2003-06-18 Combination therapy

Country Status (3)

Country Link
CN (1) CN1835757A (en)
GB (1) GB0314097D0 (en)
ZA (1) ZA200510258B (en)

Also Published As

Publication number Publication date
ZA200510258B (en) 2008-11-26
CN1835757A (en) 2006-09-20

Similar Documents

Publication Publication Date Title
GB0307918D0 (en) Therapeutic use
GB0303910D0 (en) Therapeutic agents
GB0308318D0 (en) Therapeutic agents
GB0313250D0 (en) Therapeutic agents
GB0218526D0 (en) Combination therapy
GB0326486D0 (en) Combination treatment
GB0314049D0 (en) Therapeutic agents
GB0311859D0 (en) Therapeutic agents
GB0301350D0 (en) Therapeutic agents
GB0311201D0 (en) Therapeutic agents
GB0304524D0 (en) Therapeutic agents
GB0303289D0 (en) Combination therapy
GB0325021D0 (en) Therapeutic combinations
GB0314097D0 (en) Combination therapy
GB0329512D0 (en) Combination therapy
GB0318311D0 (en) Combination therapy
GB0316184D0 (en) Combination therapy
GB0316181D0 (en) Combination therapy
GB0316176D0 (en) Combination therapy
GB0314100D0 (en) Combination therapy
GB0307560D0 (en) Combination therapy
GB0313363D0 (en) Therapeutic combinations
GB0208680D0 (en) Combination therapy
GB0218525D0 (en) Combination therapy
GB0218388D0 (en) Combination therapy

Legal Events

Date Code Title Description
AT Applications terminated before publication under section 16(1)